AI-generated summary
This prospective study treated 53 cancer patients with oral mucositis and 27 breast cancer patients with radiodermatitis using class IV laser therapy over several days. The authors report progressive improvement in mucositis grade, pain, and functional ability, and reduced ulceration and erythema, with the treatment described as beneficial for both conditions. The abstract does not describe a control group, so the findings cannot be attributed to the laser alone.
- Who or what was studied
- 53 cancer patients with oral mucositis during or after radiotherapy and/or chemotherapy, and 27 breast cancer patients with radiodermatitis
- Wavelengths
- 970 nm
- Limits stated in the abstract
- The abstract describes a prospective study without a stated control group, and radiodermatitis treatment is described as off-label use.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 5 W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Visual analogue scale, GRADE, Laser, Oral mucositis, Off-label use. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.